Bio-Rad Laboratories

Bio-Rad Laboratories

Yahoo Finance • 2 days ago

Biotechnology Reagents - Global Strategic Business Report: Capture the US$60.7 Billion Market by 2032 as Thermo Fisher, Roche, Danaher, Merck, and Bio-Rad Drive Disruption

Company Logo R&D investment, CRISPR, NGS, personalized medicine and diagnostics drive demand, while strategic partnerships accelerate reagent innovation and commercialization. Dublin, Nov. 02, 2026 (GLOBE NEWSWIRE) -- "Biotechnology Reag... Full story

Yahoo Finance • 4 days ago

Bio Rad Laboratories (BIO) Stock Looks Fully Valued After 49% Five Year Fall

Bio-Rad Laboratories has climbed back into focus after a mixed share price record, and the key issue now is whether the current US$372.18 level can be explained by the cash flows the business is expected to generate. With the Discounted Ca... Full story

Yahoo Finance • 8 days ago

BIO (BIO) vs. TMO and DHR: Can Activist Pressure Close Bio-Rad’s Valuation Discount?

Is BIO a good stock to buy? We came across a bullish thesis on Bio-Rad Laboratories, Inc. on One Idea Per Day's Substack by Paul. The thesis was published on July 21st, when the stock was trading at $281.11, and BIO has gained 32.48% since... Full story

Yahoo Finance • 23 days ago

Global Protein Labeling Market Report 2026: Size, Share, Trends, and 2030 Forecast | Capture a $4.89 Billion Market as Thermo Fisher, Merck, Bio-Rad, and Abcam Scale Automation

Company Logo Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Protein Labeling Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global protein labeling market is experiencing rapid expansion, supported by increased... Full story

Yahoo Finance • 23 days ago

Global Bioconjugation Reagents Market Report 2026: Size, Trends, and Forecast to 2030 | Accelerate ADC and Click Chemistry Growth with Thermo Fisher, Merck, Danaher, and Bio-Rad

Company Logo Bioconjugation Reagents Market to Reach $3.87 Billion by 2030 as Precision Medicine and Antibody-Drug Conjugate Demand Expands Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Bioconjugation Reagents Global Market Report 2026" has... Full story

Yahoo Finance • last month

Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and Syngene amid tariff disruption

Company Logo Biologics, biosimilars and personalized therapies are fueling CDMO outsourcing, while AI, automation and single-use systems enable scalable, compliant protein production. Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Recombinan... Full story

Yahoo Finance • last month

Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership

Company Logo Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high-throughput workflows. Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magneti... Full story

Yahoo Finance • last month

Cell Isolation/Cell Separation Market Forecasts Growth from $6.97B (2026) to $13.51B by 2032, Profiling Thermo Fisher, Bio-Rad, Beckman Coulter & Sartorius

Company Logo Opportunities include automated closed systems, AI-enabled quality control, single-cell and cell therapy workflows, precision medicine, advanced diagnostics and emerging-market expansion. Dublin, Sept. 24, 2026 (GLOBE NEWSWI... Full story

Yahoo Finance • last month

Capitalize on the Therapeutic Drug Monitoring Shift: Benchmark Roche, Abbott, Siemens Healthineers, Thermo Fisher and Bio-Rad to Accelerate Revenue and Defend Market Share

Company Logo Personalized medicine and chronic disease care are driving demand for TDM, with opportunities in consumables, automation, point-of-care devices, AI software and pharmacogenomics. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "T... Full story

Yahoo Finance • 2 months ago

Bio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual Forum

HERCULES, Calif., September 16, 2026--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K.... Full story

Yahoo Finance • 2 months ago

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share

Company Logo The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with a 34% share, while Asia Pacific is the fastest-growing region at 15.5%;... Full story

Yahoo Finance • 2 months ago

Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare Conference

HERCULES, Calif., August 31, 2026--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K. Lak... Full story

Yahoo Finance • 3 months ago

Bio-Rad (BIO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026 at 5 p.m. ET CALL PARTICIPANTS Head of Investor Relations - Ruben ArguetaChief Executive Officer - Norman SchwartzPresident and Chief Operating Officer - Jonathan DiVincenzoExec... Full story

Yahoo Finance • 3 months ago

Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Scientific

Company Logo Dublin, Aug. 11, 2026 (GLOBE NEWSWIRE) -- The "Non-Viral Transfection Reagents Market (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User and Geographical Regions-Trends and Forecast Till 2035"... Full story

Yahoo Finance • 3 months ago

Bio-Rad forecasts 2026 currency-neutral revenue growth of (-3%) to +0.5% while targeting $30M-$35M net cost savings by end of 2027

Earnings Call Insights: Bio-Rad Laboratories (BIO) Q2 2026 MANAGEMENT VIEW * "Total company revenue in the second quarter was approximately $651 million, essentially flat as reported and down 1.9% on a currency-neutral basis compared w... Full story

Yahoo Finance • 3 months ago

SR Inc Net Zero Consortium for Buyers: Seven-Buyer Aggregation for 180 MW of Millers Branch Solar Now Online

BOSTON, Aug. 4, 2026 /PRNewswire/ -- The 180 MW Phase II portion of the Millers Branch Solar Facility in Haskell County, Texas has achieved commercial operation. The capacity was contracted through Sustainability Roundtable, Inc's Net Zero... Full story

Yahoo Finance • 4 months ago

Longleaf Partners Fund exits BIO

* Longleaf Partners Fund underperformed with a return of 3.87% in Q2, as compared to the S&P 500's 15.20% gain and the Russell 1000 Value Index's 13.87% advance. * The fund initiated one new position in a healthcare company during Q2 2... Full story

Yahoo Finance • 4 months ago

Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Hematologic Malignancies Testing Market size & share revenue was valued at approximat... Full story

Yahoo Finance • 5 months ago

Global Fluorescent In Situ Hybridization Probe Market Size/Share Worth USD 2.27 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Fluorescent In Situ Hybridization Probe Market size & share revenue was valued at app... Full story

Yahoo Finance • 5 months ago

Kinaxis Unveils 2026 Customer Award Winners at Kinexions in Las Vegas

Global supply chain leaders recognized for delivering bold innovation, agility, and measurable impact LAS VEGAS, June 04, 2026--(BUSINESS WIRE)--Kinaxis® (TSX: KXS), a global leader in end-to-end supply chain planning and orchestration, t... Full story